5591490213 · Bioteknisk forskning och utveckling · BROMMA
Source: Bolagsverket and Statistics Sweden (SCB), public registers, updated continuously. A missing value does not mean the company is inactive.
Roughly 67.9 % of the balance sheet consisted of cash at the period end. Pharmability AB generated roughly 21.6 MSEK in net sales per employee in 2025.
Calculated by ArkivNord from filed annual reports. About the methodology
Positive signals from the latest annual accounts. See the Analysis tab for the full calculation behind each badge.
Net revenue
21.6 MSEK
Net result
-2.8 MSEK
▼ −7%Employees
1
Per the signatures in the annual report for the fiscal year ending 2025-12-31.
This shows who signed the most recent parsed annual report — not a live register. Positions may have changed since filing.